T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
1451
DELISTED
Ignyta, Inc.
RXDX
| $4.44M | ﹤0.01% |
359,359
+60,119
| +20% | +$620K |
|
|
LHO
1452
DELISTED
LaSalle Hotel Properties
LHO
| $4.43M | ﹤0.01% |
152,520
-14,400
| -9% | -$416K |
|
1453
ICICI Bank
IBN
$107B
| $4.42M | ﹤0.01% |
516,350
-523,565
| -50% | -$4.78M |
|
1454
Alarm.com
ALRM
$2.72B
| $4.37M | ﹤0.01% |
+96,747
| New | +$4M |
|
1455
Cartesian Therapeutics
RNAC
$262M
| $4.35M | ﹤0.01% |
7,944
| – | – |
|
|
ABMD
1456
DELISTED
Abiomed Inc
ABMD
| $4.23M | ﹤0.01% |
25,094
+7,210
| +40% | +$1.09M |
|
1457
Arch Capital
ACGL
$33.2B
| $4.23M | ﹤0.01% |
128,835
+12,831
| +11% | +$414K |
|
1458
Chemours
CC
$2.29B
| $4.19M | ﹤0.01% |
82,807
-7,080
| -8% | -$334K |
|
1459
Compass Diversified
CODI
$908M
| $4.18M | ﹤0.01% |
235,380
-521,520
| -69% | -$9.01M |
|
1460
Meritage Homes
MTH
$4.75B
| $4.09M | ﹤0.01% |
184,216
-3,600
| -2% | -$75.2K |
|
1461
Wolfspeed
WOLF
$1.64B
| $4.07M | ﹤0.01% |
144,265
-5,191
| -3% | -$129K |
|
1462
CDW
CDW
$17.1B
| $4.06M | ﹤0.01% |
61,459
+2,772
| +5% | +$173K |
|
|
ESPR
1463
DELISTED
Esperion Therapeutics
ESPR
| $3.93M | ﹤0.01% |
78,364
-3,183
| -4% | -$153K |
|
|
EV
1464
DELISTED
Eaton Vance Corp.
EV
| $3.93M | ﹤0.01% |
79,553
+8
| +0% | +$382 |
|
|
ZOES
1465
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $3.9M | ﹤0.01% |
309,150
+2,700
| +0.9% | +$32.9K |
|
1466
Heritage Insurance Holdings
HRTG
$980M
| $3.84M | ﹤0.01% |
290,496
+25,158
| +9% | +$302K |
|
1467
Cabot Corp
CBT
$4.46B
| $3.77M | ﹤0.01% |
67,531
+11,400
| +20% | +$609K |
|
1468
Cedar Fair
FUN
$1.68B
| $3.71M | ﹤0.01% |
57,897
| – | – |
|
1469
Ares Capital
ARCC
$14.3B
| $3.69M | ﹤0.01% |
225,000
| – | – |
|
|
FLG
1470
Flagstar Bank National Association
FLG
$5.9B
| $3.65M | ﹤0.01% |
94,488
-1,343
| -1% | -$50.7K |
|
|
QVCGA
1471
DELISTED
QVC Group Inc Series A
QVCGA
| $3.64M | ﹤0.01% |
3,181
-621
| -16% | -$697K |
|
|
AMAG
1472
DELISTED
AMAG Pharmaceuticals
AMAG
| $3.63M | ﹤0.01% |
196,586
-10,236
| -5% | -$191K |
|
1473
Gaming and Leisure Properties
GLPI
$12.5B
| $3.63M | ﹤0.01% |
98,295
-2,590
| -3% | -$97.8K |
|
1474
Owens Corning
OC
$12.3B
| $3.63M | ﹤0.01% |
46,861
+3,123
| +7% | +$218K |
|
|
PMBC
1475
DELISTED
Pacific Mercantile Bancorp
PMBC
| $3.62M | ﹤0.01% |
395,739
+21,969
| +6% | +$185K |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.